【ChiCTR1900027713】Comparison of the safety and efficacy of single-stage ERCP plus Laparoscopic cholecystectomy versus two-stage ERCP followed by Laparoscopic cholecystectomy 6 to 8 weeks later
ChiCTR1900027713
结束
/
/
/
2019-11-24
/
/
因胆石症和胆总管结石引起的阻塞性黄疸
Comparison of the safety and efficacy of single-stage ERCP plus Laparoscopic cholecystectomy versus two-stage ERCP followed by Laparoscopic cholecystectomy 6 to 8 weeks later
Comparison of the safety and efficacy of single-stage ERCP plus Laparoscopic cholecystectomy versus two-stage ERCP followed by Laparoscopic cholecystectomy 6 to 8 weeks later
46040
The present study aimed to assess the feasibility of performing cholecystectomy in the same session or same hospitalization following single-stage ERCP in patients with obstructive jaundice due to cholelithiasis and choledocholithiasis.
随机平行对照
其它
The cases were performed by lot by simple randomization method.
No
No financial support in this study
/
39;37;43
/
2017-10-10
2018-10-10
/
Eligibility criteria included no difficulty in ERCP, bile duct stones and cholelithiasis as demonstrated by an imaging method, no suspected or confirmed malignancy, no history of abdominal surgery and absence of contraindications for laparoscopic cholecystectomy.；
请登录查看Exclusion criteria included age under 16 years, pregnancy, diagnostic ERCP, Perforated gallbladder, suspected or confirmed malignancy and uncompleted ERCP. Patients not meeting the eligibility criteria were excluded. ERCP and LC procedures were performed by the same endoscopic surgeon. The indication for ERCP was thoroughly evaluated for each patient in consultation with a radiologist prior to the procedure.；
请登录查看No financial support in this study
46040
No financial support in this study的其他临床试验
土耳其伊玛目大学的其他临床试验
最新临床资讯
-
飞眸医疗首例人体临床试验（FIH）成功开展，国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药：超长效靶向TSLP抗体哮喘二期临床取得阳性结果，三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 20 8
-
摩熵咨询 20 11
-
摩熵咨询 34 56
-
颁布机构：国家药品监督管理局 2026-09-10
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 35 71
-
摩熵咨询 28 60
-
摩熵咨询 34 42
-
颁布机构：国家市场监督管理总局 2026-09-18
-
颁布机构：国家市场监督管理总局 2026-09-17
-
颁布机构：国家市场监督管理总局 2026-08-10